Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases

Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases

US Patent 11220549 · Granted Jan 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polynucleotides encoding antibodies that specifically bind to human IL-152025
Polynucleotides encoding antibodies that specifically bind to human IL-152025
Polynucleotides encoding antibodies that specifically bind to human IL-152025
Polynucleotides encoding antibodies that specifically bind to human IL-152025
Antibodies that specifically bind to TL1a and methods of treating gastrointestin2025
Antibodies that specifically bind to TL1a and methods of treating gastrointestin2025
Antibodies that specifically bind to TL1a and methods of treating gastrointestin2025
Antibodies that specifically bind to TL1a and methods of treating gastrointestin2025
Anti-PAR-2 antibodies and methods of use thereof2025
Anti-PAR-2 antibodies and methods of use thereof2025
Anti-PAR-2 antibodies and methods of use thereof2025
Anti-PAR-2 antibodies and methods of use thereof2025